Interim Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Dec. 31, 2021	Dec. 25, 2020
Revenue:
Revenue	$ 351,633	$ 389,874
Total revenue	351,633	389,874
Cost of revenue:
Total cost of revenue	32,709	35,304
Gross margin	318,924	354,570
Operating expenses:
Research and development	68,824	63,772
Sales and marketing	97,170	75,445
General and administrative	62,444	54,454
Gain on sale of assets	0	(13,871)
Restructuring charges/(credits)	(95)	10,023
Total operating expenses	228,343	189,823
Operating income	90,581	164,747
Other income/(expense):
Interest income	716	974
Interest expense	(84)	(85)
Other income, net	229	1,326
Total other income	861	2,215
Provision for income taxes	(11,432)	(24,272)
Net income including controlling interest	80,010	142,690
Less: net (income)/loss attributable to controlling interest	4	(7,492)
Net income attributable to Dolby Laboratories, Inc.	$ 80,014	$ 135,198
Net income per share:
Basic (in usd per share)	$ 0.79	$ 1.34
Diluted (in usd per share)	$ 0.77	$ 1.30
Weighted-average shares outstanding:
Basic (in shares)	101,230	100,716
Diluted (in shares)	103,801	103,876
Cash dividend declared per common share (in dollars per share)	$ 0.25	$ 0.22
Cash dividend paid per common share (in dollars per share)	$ 0.25	$ 0.22
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ 91,442	$ 166,962
Licensing
Revenue:
Revenue	332,284	373,005
Cost of revenue:
Cost of revenue	14,935	12,946
Products and services
Revenue:
Revenue	19,349	16,869
Cost of revenue:
Cost of revenue	$ 17,774	$ 22,358